Acadian Asset Management LLC Exact Sciences Corp Transaction History

Acadian Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$41.33 - $74.26 $157,839 - $283,598	3,819 New	3,819 $160,000
Q2 2021 Aug 11, 2021	SELL	$93.66 - $139.27 $104,992 - $156,121	-1,121 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$116.57 - $155.01 $345,979 - $460,069	-2,968 Reduced 72.58%	1,121 $148,000
Q4 2020 Feb 11, 2021	BUY	$99.61 - $142.12 $407,305 - $581,128	4,089 New	4,089 $542,000
Q1 2018 Apr 12, 2018	SELL	$39.82 - $57.53 $6,092 - $8,802	-153 Closed	0 $0
Q3 2017 Oct 13, 2017	BUY	$37.05 - $47.12 $5,668 - $7,209	153	153 $7,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.